COVID in Semen: Transmission Risk and Sperm Quality

SARS-CoV-2 RNA has turned up in semen only rarely, and almost exclusively during acute infection. The vast majority of studies testing semen from COVID-19 patients have found no trace of the virus, and no confirmed case of sexual transmission has been documented. The more pressing concern for reproductive health is not viral presence in semen itself but the indirect damage COVID-19 can inflict on sperm quality, testosterone levels, and testicular tissue, most of which appears to be temporary.

How Often Has the Virus Actually Been Found in Semen?

If you search the research literature for studies that tested semen samples from men with active or recent COVID-19, the pattern is consistent: the virus almost never shows up. In a French study of patients in the acute stage of infection, only one out of the cohort had detectable SARS-CoV-2 in his semen and seminal plasma, while the sperm cells themselves tested negative.¹ An Indian pilot study of 37 semen samples from men with active infection found zero positives.² A prospective observational study concluded that semen is not infectious with SARS-CoV-2 at one week or more after infection, with samples collected an average of 53 days post-diagnosis all coming back negative.³

A comparative review looking across the early pandemic literature found that only two studies had ever detected SARS-CoV-2 RNA in semen, while seven reported no positive detections at all.⁴ Even in studies that did find a positive signal, there was no proof that the detected RNA represented live, infectious virus rather than harmless genetic fragments. This is a meaningful distinction: finding viral RNA is not the same as finding virus that could infect someone else.

Why Detection Has Been So Inconsistent

Part of the confusion comes from the testing itself. The standard method used to look for SARS-CoV-2 in semen, real-time reverse transcriptase PCR, was designed and validated for respiratory samples like nasal swabs. When applied to seminal fluid, its reliability is less certain. Seminal fluid contains substances that can interfere with the test, potentially producing false negatives. At the same time, contamination or low specificity can lead to false positives. Critically, the sensitivity and specificity of these PCR methods for detecting SARS-CoV-2 specifically in semen have never been formally evaluated.⁵

This means the handful of positive semen results need to be interpreted cautiously. A positive could be real, or it could be an artifact. And a negative does not guarantee the virus was never there, just that it was not detected at that moment with that test. The timing of sample collection matters too: most studies collected semen days to weeks after symptom onset, by which time any seminal viral presence may have already cleared.

How the Virus Could Reach the Testes in the First Place

SARS-CoV-2 enters human cells by latching onto a receptor called ACE2, often with the help of a protein called TMPRSS2 that primes the virus for entry. The question of whether these receptors exist in testicular tissue has produced conflicting answers. One study suggested limited expression of both ACE2 and TMPRSS2 in the testes and no overlap between them in the same cells, making viral entry unlikely. But other research has found ACE2 on several testicular cell types, including the Leydig cells that produce testosterone and the Sertoli cells that support sperm development, along with spermatogonia. TMPRSS2 was also found on sperm-producing cells at various stages of development.⁶ In short, the molecular doorways for viral entry appear to be present in the testes, though whether the virus routinely exploits them during a typical infection is another matter.

Adding to this picture, the testes have a specialized defense called the blood-testis barrier, a tight layer of junctions between Sertoli cells that shields developing sperm from immune attack and pathogens. Research has shown that COVID-19 can weaken this barrier. In infected patients, inflammatory molecules were significantly elevated in testicular tissue, while the proteins that hold the barrier’s junctions together were reduced.⁷ A compromised barrier could allow the virus, or at least the inflammatory damage it triggers, to reach the cells where sperm are made.

What COVID Does to Sperm Quality

Even though the virus itself rarely shows up in semen, the infection can clearly affect the sperm it carries. A meta-analysis of observational studies found that COVID-19 lowered total sperm count, sperm concentration, motility, progressive motility, and viability.⁸ During the illness itself, semen volume dropped. In the recovery phase, sperm concentration and motility remained impaired for roughly three months.

The reassuring finding across multiple studies is that these changes are temporary. One study of men who had recovered from both mild and severe COVID-19 found reduced semen volume, lower total sperm counts, and impaired motility and viability shortly after infection, but all of these measures returned to normal after three or more months.⁹ A longer follow-up study found that total sperm number was still lower than controls at around four to five months post-recovery, but by five months and beyond, no significant differences remained.¹⁰ The timeline is consistent with what’s known about the sperm production cycle, which takes roughly 74 days from start to finish. Once the insult is removed, a new batch of unaffected sperm eventually replaces the damaged ones.

Is It the Fever or the Virus Itself?

High body temperature has long been known to hurt sperm production. The testes sit outside the body in the scrotum specifically because sperm develop best a few degrees below core body temperature. Any illness that causes a sustained fever can temporarily reduce sperm quality, not just COVID-19. So an obvious question is whether the sperm changes seen after COVID are simply a fever effect, or something more specific to this virus.

The honest answer is that researchers have not been able to fully untangle this. One review noted that while fever is a common symptom among the cases studied, it cannot be confirmed as the primary factor behind impaired sperm quality.¹¹ The decline likely results from a combination of fever, systemic inflammation, immune response, and oxidative stress. The inflammatory pathway that disrupts the blood-testis barrier represents a mechanism that goes beyond simple heat damage.¹² Men with asymptomatic infections, who presumably had minimal or no fever, have also shown some hormonal changes, which hints that the virus does have effects independent of temperature.

Testosterone and Hormonal Disruption

Beyond sperm parameters, COVID-19 can knock testosterone levels down. A systematic review and meta-analysis found that SARS-CoV-2 infection led to reduced circulating testosterone while raising levels of luteinizing hormone, estrogen, and prolactin.¹³ The elevated luteinizing hormone alongside low testosterone suggests the problem originates in the testes themselves: the brain’s hormonal signals are trying to stimulate testosterone production, but the testes are not responding normally.

A 2024 study that tracked both symptomatic and asymptomatic patients over six months found that men with COVID symptoms had significantly lower testosterone and a higher ratio of luteinizing hormone to testosterone. Encouragingly, testosterone rose significantly by three months and continued improving at six months in symptomatic patients. Even asymptomatic patients, who started from a less-disrupted baseline, saw measurable improvement by three months.¹⁴ As with sperm quality, the hormonal effects appear reversible for most men, though the timeline may stretch longer than many expect.

There is an overlap here with erectile dysfunction. A case-controlled study of men who developed erectile dysfunction three months after recovering from mild-to-moderate COVID found that their total and free testosterone levels were significantly lower than those of healthy controls, and their luteinizing hormone was elevated.¹⁵ Whether long COVID-associated erectile dysfunction is primarily hormonal, vascular, or psychological is still being sorted out, but the testosterone data suggest a hormonal component for at least some men.

Testicular Damage Seen at Autopsy

The strongest evidence that SARS-CoV-2 directly infects the testes comes from autopsy studies of men who died of severe COVID-19. These findings represent worst-case scenarios rather than typical outcomes, but they are revealing. In one autopsy series, all cases showed congestion, swelling between the tubules, thickening of the tubular membranes, decreased numbers of both Leydig and Sertoli cells, and reduced sperm production. SARS-CoV-2 antigen was found in Leydig cells, Sertoli cells, and spermatogonia in every case. Electron microscopy identified actual viral particles inside cells in the majority of cases.¹⁶

A separate autopsy study of eleven patients found significant Sertoli cell injury, with cells swelling, detaching from the tubule walls, and sloughing into the tubes’ centers. The average number of Leydig cells was dramatically lower in COVID-19 patients compared to controls. Interestingly, this study did not find viral particles on electron microscopy and detected the virus by PCR in only one of twelve cases, suggesting that much of the damage may be driven by inflammation rather than direct viral killing of cells.¹⁷ These two studies paint a broadly similar picture of testicular harm in fatal COVID-19, but they disagree on how often the virus itself is physically present in the tissue, which underscores just how much the field is still working this out.

Sexual Transmission Risk

Given the rarity of viral detection in semen, the risk of sexually transmitting SARS-CoV-2 through seminal fluid appears very low. No case of sexual transmission through semen has been confirmed. A comparative review noted that while Zika and Ebola were both found in semen and confirmed to be sexually transmitted (prompting the World Health Organization to update prevention guidelines for those viruses), SARS-CoV-2 has not followed the same pattern.¹⁸

That said, sexual contact itself is an obvious route for COVID-19 transmission through respiratory droplets and close-range aerosols, kissing, and shared air. One review emphasized that sexual intercourse should not be dismissed as a context for COVID transmission, though the mechanism is primarily respiratory rather than through genital fluids.¹⁹ The practical distinction matters: the risk from sex is the closeness of contact, not the semen.

Do COVID Vaccines Affect Semen?

One of the most persistent myths during the pandemic was that COVID-19 vaccines would damage male fertility. A systematic review and meta-analysis specifically examined whether inactivated or mRNA COVID-19 vaccines affected semen quality and found no discernible change in any parameter before versus after vaccination.²⁰ The irony is that the infection itself demonstrably harms sperm quality in the short term, while vaccination does not.

A separate line of research has looked at anti-sperm antibodies, which can reduce sperm motility and contribute to infertility. One study found that IgA antibodies could bind to proteins on sperm, affecting motility and other parameters, and suggested this could be exacerbated by either COVID-19 infection or vaccination.²¹ This is a newer and less established area of inquiry. The anti-sperm antibody hypothesis does not contradict the broader meta-analytic finding that vaccines leave overall semen parameters unchanged, but it does suggest there are more subtle immune interactions worth tracking in future research.

Implications for Fertility Clinics and Sperm Banks

When early pandemic reports hinted at virus in semen, IVF laboratories had to make quick decisions about safety protocols. Some lab managers initially considered sweeping precautions: extra care in semen handling, switching to closed cryopreservation systems, using a technique called ICSI (which injects a single sperm directly into an egg) for all patients to minimize fluid exposure, and quarantining liquid nitrogen containers used during the pandemic. But as the evidence accumulated showing that seminal viral presence was rare and likely not infectious, these extra measures were largely dropped.²²

More recent work has offered further reassurance for cryopreservation. A study that tested spermatozoa from COVID-exposed patients found that while a small number tested positive for a viral gene marker before freezing, both slow conventional cryopreservation and vitrification eliminated the detectable signal.²³ The freezing process itself appears to neutralize any residual viral material. For men banking sperm after a COVID-19 infection, the practical advice based on current evidence is to wait at least a few months for sperm quality to recover, though the stored samples themselves are unlikely to harbor infectious virus.

What Zika and Ebola Taught Us, and How COVID Differs

The concern about viruses in semen is not new, and the contrast with other viruses puts the COVID findings in perspective. Zika virus can persist in semen for months after the bloodstream has cleared it, and sexual transmission of Zika has been confirmed often enough that the WHO issued specific guidelines recommending abstinence or condom use after infection. Ebola virus has been detected in semen more than a year after recovery, and at least one outbreak was linked to sexual transmission from a survivor. Both of these viruses can replicate inside the testes in ways that allow long-term shedding.²⁴

SARS-CoV-2 has not followed this pattern. Its detection in semen has been sporadic and limited to the acute phase of illness, with no evidence of prolonged seminal shedding and no proven sexual transmission. The testes may be partially vulnerable to the virus, but they do not appear to serve as a long-term reservoir the way they can for Zika or Ebola. This is one of the more reassuring things the pandemic research has established, even as many questions about the virus’s reproductive effects remain open.

Practical Guidance for Men Concerned About Fertility After COVID

For men who are trying to conceive, the research points to a fairly straightforward timeline. Sperm parameters and testosterone levels tend to recover within three to six months of infection, with the meta-analytic data suggesting that the most substantial improvements happen by roughly the three-month mark.²⁵ Men who had severe infections or prolonged symptoms may take longer, and those experiencing persistent low testosterone or erectile dysfunction after COVID should consider getting their hormone levels checked rather than assuming the problem is purely psychological.

If you are undergoing fertility treatment, the consensus from reproductive medicine has moved away from the aggressive containment measures considered early in the pandemic. Semen samples collected after the acute phase of infection carry negligible viral risk, and cryopreservation appears to eliminate any trace of viral material that might be present.²⁶ The more relevant consideration is timing your sample collection far enough from your infection that sperm quality has had a chance to bounce back. Given what the studies show, waiting at least three months after recovery, and longer if you had a rough course, is a reasonable approach to ensure the sample reflects your normal baseline rather than a temporarily suppressed state.